AI assistant
Vidrala S.A. — Investor Presentation 2023
Jul 19, 2023
1897_rns_2023-07-19_9840a538-3b63-48f0-8e09-045ec7ca5044.pdf
Investor Presentation
Open in viewerOpens in your device viewer
H1 2023 RESULTS
19th JULY 2023

DISCLAIMER
This presentation includes or may include representations or estimations concerning the future about intentions, expectations or forecasts of VIDRALA or its management. which may refer to the evolution of its business performance and its results. These forward-looking statements refer to our intentions, opinions and future expectations, and include, without limitation, statements concerning our future business development and economic performance. While these forward-looking statements represent our judgment and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, (1) general market, macro-economic, governmental and regulatory trends, (2) movements in local and international securities markets, currency exchange rates and interest rates as well as commodities, (3) competitive pressures, (4) technological developments, (5) changes in the financial position or credit worthiness of our customers, obligors and counterparties.
The risk factors and other key factors that we have indicated in our past and future filings and reports, including those with the regulatory and supervisory authorities (including the Spanish Securities Market Authority – Comisión Nacional del Mercado de Valores - CNMV), could adversely affect our business and financial performance. VIDRALA expressly declines any obligation or commitment to provide any update or revision of the information herein contained, any change in expectations or modification of the facts, conditions and circumstances upon which such estimations concerning the future have been based, even if those lead to a change in the strategy or the intentions shown herein.
This presentation can be used by those entities that may have to adopt decisions or proceed to carry out opinions related to securities issued by VIDRALA and, in particular, by analysts. It is expressly warned that this document may contain not audited or summarised information. It is expressly advised to the readers of this document to consult the public information registered by VIDRALA with the regulatory authorities, in particular, the periodical information and prospectuses registered with the Spanish Securities Market Authority – Comisión Nacional del Mercado de Valores (CNMV).

| H1 2023 | Change | Change at constant currency basis |
|
|---|---|---|---|
| Sales (EUR million) |
794.8 | +22.1% | +23.9% |
| EBITDA (EUR million) |
215.2 | +92.2% | +94.0% |
| Earnings per share (EUR) |
4.19 | +131.6% | |
| Debt (EUR million) |
283.8 | +32.0% | |
| Debt / LTM EBITDA (multiple) |
0.8x | -0.1x |


YEAR OVER YEAR CHANGE EUR million




OPERATING MARGIN

MARGIN TREND OVERVIEW
EBITDA MARGINS (LTM)
As percentage of sales, on a last twelve months (LTM) basis

CASH PROFILE
FREE CASH FLOW GENERATION LAST 12 MONTHS TO JUNE 2023
EUR million / as percentage of sales



YEAR OVER YEAR EVOLUTION, SINCE 2019
EUR million and times EBITDA

H1 2023 RESULTS | Main highlights


TOP-LINE GROWTH OF 23.9%
Sales during the first six months 2023 amounted to EUR 794.8 million, showing a growth of 23.9% on a constant currency basis
OPERATING MARGIN OF 27.1%
Operating profit, EBITDA, was EUR 215.2 million representing an operating margin of 27.1%
LEVERAGE AT 0.8x EBITDA
Net debt as of June 30, 2023 stood at 0.8 times last twelve months EBITDA
RECENT M&A
Acquisition of 'The Park' bottling and logistic facilities (UK) and a non-controlling minority stake of 29.36% in Vidroporto (Brazil)
FY 2023 OUTLOOK, REITERATED
| Actuals FY 2022 |
Last Twelve Months as of June 2023 |
FY 2023 Trends |
|
|---|---|---|---|
| Sales variation |
+23.9% YoY organic |
+25.8% YoY organic |
Sustained double-digit revenue growth driven by price/mix effect, despite progressively lower contribution mostly due to higher comparable base. |
| EBITDA margin |
20.1% EBITDA/sales |
25.1% EBITDA/sales |
EBITDA margin consolidated at levels above 25% over sales, supported on benefits from recent investments, cost actions and internal efficiencies. |
| Earnings | EUR 4.97 per share |
EUR 7.36 per share |
FY 2023 earnings to exceed EUR 7.00 per share, following the above-mentioned operational profits recovery and recent M&A. |
| Leverage ratio |
0.6x debt/EBITDA |
0.8x debt/EBITDA |
Leverage to remain below 0.8x net debt-to-EBITDA, excluding pending M&A. FY 2023 free cash flow to exceed EUR 150 million. |




ANNEX | ALTERNATIVE PERFORMANCE MEASURES (APM)

Vidrala publishes this information in order to promote comparability and interpretation of its financial information and in compliance with the Directive of the European Securities and Markets Authority (ESMA) on Alternative Performance Measures (APM).
See below, the alternative performance measures used by Vidrala, as well as its basis of calculation. For further detail, please check the reference document published on the corporate website (link), as well as the reconciliation provided on the next slide of this presentation.
EBITDA. Vidrala calculates EBITDA as earnings before interest, taxes, depreciation and amortization (as reported in the consolidated income statement).
Consolidated net debt. Vidrala calculates consolidated net debt as the sum of all long-term liabilities and short-term obligations, and then subtracting cash and cash equivalents (as reported in the consolidated balance sheet). Reported net debt excludes the impact of IFRS 16 Leases (see note 18 of the consolidated financial statements for further details).
Free cash flow. Vidrala calculates free cash flow by adding –to the real variation in net debt balances (as reported in the consolidated balance sheet)– payments during the period dedicated to dividends and net treasury stock purchases (as reported in the consolidated statement of cash flows).
Other magnitudes referred to in this report:
- EBITDA margin is calculated as accumulated EBITDA during the reported period divided by net sales.
- Organic refers to the variation on a like-for-like (comparable perimeter) and constant currency basis.
- Debt/EBITDA ratio is calculated as consolidated net debt at the end of the reported period divided by EBITDA obtained in the last 12 months.
ANNEX | ALTERNATIVE PERFORMANCE MEASURES (APM)
| EUR '000 | H1 2023 | H1 2022 | Source of data |
|---|---|---|---|
| Profit before income tax from continuing operations | 163,362 | 70,593 | Consolidated Income Statement |
| Amortisation and depreciation | +50,787 | +43,950 | Consolidated Income Statement |
| Finance income | -3,142 | -249 | Consolidated Income Statement |
| Finance costs | +6,170 | +1,609 | Consolidated Income Statement |
| Impairment of non-current assets | +907 | +723 | Consolidated Income Statement |
| Change in fair value of financial instruments | +0 | -4,638 | Consolidated Income Statement |
| Participation accounted through equity method | -2,888 | +0 | Consolidated Income Statement |
| Reported EBITDA | 215,196 | 111,988 | / |
ii) Consolidated net debt
i) EBITDA
| EUR '000 | H1 2023 | H1 2022 | Source of data |
|---|---|---|---|
| Loans and borrowings (non-current liabilities) | 355,296 | 256,055 | Consolidated Balance Sheet |
| Loans and borrowings (current liabilities) | +38,622 | +74,241 | Consolidated Balance Sheet |
| Cash and cash equivalents | -62,558 | -115,267 | Consolidated Balance Sheet |
| IFRS 16 Leases impact | -47,590 | -571 | Note 18 – Financial Liabilities |
| Reported consolidated net debt | 283,770 | 214,458 | / |

iii) Free Cash Flow*
| EUR '000 | H1 2023 | H1 2022 | Source of data |
|---|---|---|---|
| Year-over-year change in net debt balances |
-69,312 | -42,357 | Consolidated Balance Sheets |
| Dividends paid** |
+36,740 | +34,158 | Consolidated Statements of Cash Flows |
| Annual General Meeting attendance bonus |
+1,050 | +1,015 | Note 16(c) – Equity |
| Proceeds from issue of treasury shares and own equity instruments** |
+0 | +0 | Consolidated Statements of Cash Flows |
| Payments to redeem own shares and other own equity instruments** |
+10,985 | +22,064 | Consolidated Statements of Cash Flows |
| Acquisition of a subsidiary, net of adquired cash |
+87,225 | +0 | Consolidated Statements of Cash Flows |
| IFRS 16 Leases impact | -1,776 | +480 | Note 18 – Financial Liabilities |
| Reported Free Cash Flow last twelve months | 64,912 | 15,360 | / |

* Free cash flow is presented on a full-year, last twelve months basis.
** Figures are calculated from full-year 2022 financial statements less first half 2022 plus first half 2023.

VIDRALA, S.A. Investor Relations Tel: +34 94 671 97 50 [email protected] www.vidrala.com
